A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds. In fact, cancer patients who were given psilocybin reported reductions in anxiety, depression, hopelessness, demoralization, and death anxiety more than four years after receiving the dose in combination with psychotherapy.
A recent wave of research is supporting the argument that psychedelics could be a key to improving mental health for patients who don’t respond well to conventional treatments. The controversial class of drugs, which includes LSD and MDMA, have always generated research attention (several were created in labs as potential treatments before becoming street drugs),
A new study adds support to claims that the psychedelic drug psilocybin, when combined with psychotherapy, can effectively treat depression and anxiety years after taking the drug. The research follows up on a 2016 study that tested the effects of a single-dose, one-time use of psilocybin combined with psychotherapy on depression and anxiety symptoms among